Phasebio pharmaceuticals inc.

Major-Pharmaceuticals

PHAS


1 Great Valley Parkway
Malvern , PA 19355

Executive/
Director

Links

Price

  • Last Close
  • $ 0.9
    $ -0.02 -2.17 %
    Sep 21, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 134,000
  • Market Cap Full
  • $ 44.9M
  • Shares Outstanding
  • 49.9M
    Aug 8, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - 207.8% -5% 3% -43.7% - -
Q2 - - - - 4.2% 4% 7.5% -59.2% - -
Q3 - - - - -67% 8% -16.4% 50% - -
Q4 - - - -38.2% 42.6% -4.3% -16.1% - - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 - - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%103%-46%-22%-66%0%0%

Earnings

2015 2016 2017 2018 2019 2020 2021
Q1 - - - -5.9 -0.3 -0.52 -0.87
Q2 - - - -8.95 -0.33 -0.98 -0.6
Q3 - - - -10.45 -0.4 -0.86 -
Q4 - - - - -0.4 -1.03 -
A 0 0 0 -25.3 -1.4 -3.4 -3

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - 24.5 28.8 29.4 48.7
Jun - 28.6 28.8 48 48.7
Sep - 28.7 29.3 48 49.9
Dec 24.5 28.8 29.4 48.1 -

Financial Ratios

2020201920182017
Asset Management
Inventory / Stock Turnover - - - -
Fixed Asset Turnover - 0.6 1.7 -
Total Asset Turnover - - - -
Leverage
Debt Ratio 0.2 0.2 0.1 0.2
Debt – Equity Ratio -0.3 0.2 0.2 -0.3
Interest Coverage -6.2 81.3 -4.7 -5
Equity multiplier -0.4 0.1 - -